# Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

> **NCT00136058** · PHASE3 · COMPLETED · sponsor: **University of Alberta** · enrollment: 250 (—)

## Conditions studied

- Osteoporosis

## Interventions

- **PROCEDURE:** bone densitometry (DEXA)
- **DRUG:** alendronate or risedronate

## Key facts

- **NCT ID:** NCT00136058
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 250 (—)
- **Last updated:** 2011-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136058, "Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00136058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*